《大行報告》花旗:中國海外(00688.HK)去年業績符預期 每股派息增16%
中國海外(00688.HK)今日股價彈高6.3%收21.8元。花旗發表報告表示,中國海外去年扣除投資物業公允價值變動後的核心盈利按年升10.9%至380.3億人民幣,符合該行此前預測371億元人民幣。該行指,中海外去年業績受到外匯匯兌淨收益達31億人民幣所支持,其毛利率下滑3.6個百分點至30.05%。
該行指,中國海外截至去年12月底淨借貸比率維持於32.6%,全年每股派息118港仙,按年升15.7%,核心派息比率為28.6%(對比2019年為28.4%)。
花旗維持中國海外「買入」評級及目標價21元。(wl/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.